Ingevity NGVT Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$127.8M+23.5% | -$167.1M-103% | -$82.5M+64.6% | -$233.2M+37.0% | -$370.4M+17.1% | ||
| $104.2M-2.1% | $106.4M+2.6% | $103.7M+1.8% | $101.9M-1.6% | $103.6M-4.3% | ||
| $19M+3.8% | $18.3M+15.1% | $15.9M+16.1% | $13.7M+17.1% | $11.7M-1.7% | ||
| $11.7M+349% | -$4.7M-145% | $10.5M+122% | -$47.9M+53.9% | -$103.9M+14.4% | ||
| —— | —— | —— | -$165.3M— | $0— | ||
| $29.4M+212% | -$26.2M-948% | -$2.5M+72.8% | -$9.2M-39.4% | -$6.6M+42.1% | ||
| -$9.3M+23.8% | -$12.2M-8.0% | -$11.3M+49.1% | -$22.2M+18.1% | -$27.1M+29.1% | ||
| -$28.8M+28.4% | -$40.2M+21.0% | -$50.9M+43.2% | -$89.6M-8.1% | -$82.9M-13.1% | ||
| —— | —— | —— | —— | -$51.6M+18.6% | ||
| -$11.3M+19.9% | -$14.1M-74.1% | -$8.1M-8.0% | -$7.5M— | —— | ||
| $1.1M+185% | -$1.3M— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| -$3M-150% | -$1.2M-71.4% | -$700K-110% | $6.7M+168% | -$9.9M+28.3% | ||
| $303.8M-8.3% | $331.2M+10.9% | $298.6M+38.6% | $215.4M+29.7% | $166.1M+29.2% | ||
| $58M+0.5% | $57.7M-2.2% | $59M-9.4% | $65.1M-8.3% | $71M-8.5% | ||
| —— | —— | —— | —— | —— | ||
| -$3.9M— | $0+100% | -$9.9M-371% | -$2.1M-130% | $7M+338% | ||
| —— | —— | —— | —— | —— | ||
| $60.3M+205% | -$57.5M+18.3% | -$70.4M-17.9% | -$59.7M+20.1% | -$74.7M+6.0% | ||
| —— | —— | —— | —— | $0— | ||
| $912.8M+213% | $291.3M-37.2% | $463.5M+4.7% | $442.8M+6.6% | $415.4M+2.7% | ||
| $1.1B+128% | $483.6M+110% | $230.7M+57.8% | $146.2M+223% | $45.3M— | ||
| —— | —— | —— | —— | $0— | ||
| $5.4M+45.9% | $3.7M+23.3% | $3M+3.4% | $2.9M-6.5% | $3.1M0.0% | ||
| —— | —— | —— | —— | $0— | ||
| -$303M-20.1% | -$252.2M+5.3% | -$266.4M-49.7% | -$177.9M-70.1% | -$104.6M-49.0% | ||
| $3.7M-24.5% | $4.9M+644% | -$900K-123% | $4M+500% | -$1M+76.2% | ||
| $66.2M+138% | $27.8M+171% | -$39.1M-115% | -$18.2M-28.2% | -$14.2M+43.9% | ||
| $66.9M-5.0% | $70.4M-6.3% | $75.1M-6.5% | $80.3M-3.3% | $83M-2.8% | ||
| $9M-17.4% | $10.9M+9.0% | $10M-2.9% | $10.3M-63.7% | $28.4M+5.6% | ||
| $19M+3.8% | $18.3M+15.1% | $15.9M+16.1% | $13.7M+17.1% | $11.7M-1.7% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | $109.3M+33.3% | $81.98M+50.0% | $54.65M+100% | $27.33M— | ||
| $1.8M-73.9% | $6.9M+35.3% | $5.1M+24.4% | $4.1M+95.2% | $2.1M-73.8% | ||
| —— | —— | —— | —— | $20.4M-56.0% | ||
| $18.3M-6.2% | $19.5M+1.6% | $19.2M-10.7% | $21.5M+0.9% | $21.3M-1.8% | ||
| —— | —— | —— | —— | —— | ||
| $1.1M+185% | -$1.3M— | —— | —— | —— | ||
| -$43.1M+6.5% | -$46.1M+9.3% | -$50.8M+14.6% | -$59.5M+2.3% | -$60.9M-2.7% | ||
| —— | —— | -$13.1M+9.0% | -$14.4M-1,700% | $900K+116% | ||
| —— | $14.7M-7.0% | $15.8M-6.5% | $16.9M-6.1% | $18M-5.8% | ||
| —— | —— | —— | —— | —— | ||
| -$10.1M-32.9% | -$7.6M+49.7% | -$15.1M+1.9% | -$15.4M-58.8% | -$9.7M+42.9% | ||
| —— | $1.2M-5.9% | $1.28M-5.6% | $1.35M-5.3% | $1.43M-5.0% | ||
| $51.7M-7.2% | $55.7M-17.5% | $67.5M-53.3% | $144.5M+6.5% | $135.7M-27.1% | ||
| -$3.9M— | $0+100% | -$9.9M-371% | -$2.1M-130% | $7M+338% | ||
| —— | —— | —— | —— | $0— | ||
| —— | —— | —— | —— | —— | ||
| -$1.2M+7.7% | -$1.3M-30.0% | -$1M0.0% | -$1M0.0% | -$1M0.0% | ||
| —— | —— | —— | —— | $0— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $7.6M+322% | $1.8M+20.0% | $1.5M-66.7% | $4.5M-19.6% | $5.6M-6.7% | ||
| $9M-17.4% | $10.9M+9.0% | $10M-2.9% | $10.3M-63.7% | $28.4M+5.6% | ||
| $245.8M-10.1% | $273.5M+14.1% | $239.6M+59.4% | $150.3M+58.0% | $95.1M+86.5% | ||
| $245.8M-10.1% | $273.5M+14.1% | $239.6M+59.4% | $150.3M+58.0% | $95.1M+86.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Ingevity generate?
- Ingevity (NGVT) generated $303.8M in operating cash flow over the trailing twelve months.
- What is Ingevity's free cash flow?
- After $58.0M of capital expenditures, Ingevity's free cash flow was $245.8M over the trailing twelve months, up 158.5% year over year.
- Where does Ingevity's cash flow data come from?
- Every line is extracted from Ingevity's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
